Dauphine Organics

Dauphine Organics is a clinical-stage life sciences company dedicated to the research, development, and commercialization of plant-derived pharmaceutical products. The company focuses on high-purity cannabinoid-based medicines targeting unmet needs in neurology, oncology, and pain management. Utilizing a proprietary extraction and purification platform, Dauphine Organics produces pharmaceutical-grade active ingredients and finished drug products. Their clinical pipeline includes programs for multiple sclerosis, epilepsy, and palliative care in cancer patients. By adhering to strict GMP standards and conducting rigorous clinical trials, the company aims to provide standardized, evidence-based botanical therapies to the global healthcare market.